|
|
| (No se muestran 2 ediciones intermedias del mismo usuario) |
| Línea 1: |
Línea 1: |
| == Exposure Estimated Risk ==
| | #REDIRECT[[HIV post-exposure prophylaxis]] |
| | |
| {| style="width: 500px" border="1" cellpadding="1" cellspacing="1"
| |
| |-
| |
| | '''Exposure<br/>'''
| |
| | '''Risk<br/>'''
| |
| |-
| |
| | Percutaneous
| |
| | 0.3%
| |
| |-
| |
| | Mucocutaneous
| |
| | 0.09%
| |
| |-
| |
| | Needle-sharing injection drug
| |
| | 0.7%
| |
| |-
| |
| | Receptive anal intercourse
| |
| | 0.5%
| |
| |-
| |
| | Receptive penile-vaginal intercourse
| |
| | 0.1%
| |
| |-
| |
| | Insertive anal intercourse
| |
| | 0.07%
| |
| |-
| |
| | Insertive penile-vaginal intercourse
| |
| | 0.05%
| |
| |-
| |
| | Receptive oral (male) intercourse
| |
| | 0.01%
| |
| |-
| |
| | Insertive oral (male) intercourse
| |
| | 0.005%
| |
| |}
| |
| | |
|
| |
| | |
| *assumes no condom use
| |
| | |
| | |
| | |
| == Source ==
| |
| | |
| 8/07 DONALDSON
| |
| | |
| <br/>[[Category:ID]]
| |
